Simcere Pharmaceutical Group Company Profile

Simcere Pharmaceutical Group

No. 699-18 Xuan Wu Ave.,
Xuan Wu District
Nanjing, Jiangsu 210042
China
Tel: 86/25-8556-6666
URL: http://www.simcere.com
Primary Symbols & Exchanges:
SCR - New York Stock Exchange
Primary Industry:
Pharmaceutical
SIC Industry Code:
NAICS Industry Code:
Simcere Pharmaceutical Group Mergers and Acquisitions
Thomson Financial Business Description:
The Group's principal activity is manufacturing and selling 35 pharmaceutical products, including antibiotics, an anti-cancer medication and an anti-stroke medication. Other activities include the distribution of three additional pharmaceuticals that are marked under brand names Yingtaiqing, Anqi, and Biqi including anti-inflammatory pain relievers. It introduced a first-to-market generic anti-stroke medication under the brand name Bicun, and an anti-cancer medication under the brand name Endu, also known as Endostar. It operates solely in the domestic market.
Alacra Alerts: Simcere Pharmaceutical Group RSS Feed  Subscribe with My Yahoo!
Receive alerts on the latest reports on Simcere Pharmaceutical Group

Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:







Search for more premium content on Simcere Pharmaceutical Group
  about us contact us public company index private company index pcan widget your privacy rights terms & conditions